Captrust Financial Advisors Astellas Pharma Inc Unsponsore Transaction History

Captrust Financial Advisors

$33 Billion
Q3 2024

Shares

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2022 Aug 23, 2022	BUY	$14.54 - $16.7 $14,481 - $16,633	996 Added 24.36%	5,085 $79,000
Q1 2022 May 16, 2022	BUY	$15.53 - $17.95 $4,643 - $5,367	299 Added 7.89%	4,089 $64,000
Q4 2021 Feb 14, 2022	BUY	$15.28 - $17.56 $6,127 - $7,041	401 Added 11.83%	3,790 $62,000
Q2 2021 Aug 16, 2021	BUY	$14.72 - $18.22 $1,221 - $1,512	83 Added 2.51%	3,389 $59,000
Q1 2021 May 17, 2021	BUY	$15.27 - $17.41 $6,352 - $7,242	416 Added 14.39%	3,306 $51,000
Q4 2020 Feb 16, 2021	BUY	$13.63 - $15.95 $22,762 - $26,636	1,670 Added 136.89%	2,890 $45,000
Q3 2020 Nov 17, 2020	BUY	$14.91 - $16.52 $14,313 - $15,859	960 Added 369.23%	1,220 $18,000
Q2 2020 Aug 14, 2020	BUY	$14.59 - $18.42 $3,793 - $4,789	260 New	260 $4,000

Others Institutions Holding ALPMY

# of Institutions

5

Shares Held

208K

Call Options Held

0

Put Options Held

0

About Astellas Pharma Inc Unsponsore

Ticker ALPMY
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,827,069,952
Market Cap $17.9B

More about ALPMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Captrust Financial Advisors with notifications on news.